New Key Statistics Module, Z-Score and F-Score
OTCPK:RLFTF Key Ratios
| Market Cap $ M | 17.37 |
| Enterprise Value $ M | 5.08 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.31 |
| Price/Sales | 2.55 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -9.43 |
| Beneish M-Score | -1.79 |
| 10-y EBITDA Growth Rate % | -9.00 |
| 5-y EBITDA Growth Rate % | -131.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.04 |
| EV-to-EBITDA | -0.04 |
| PEG | -- |
| Shares Outstanding M | 12.54 |
| Net Margin (%) | -1,627.40 |
| Operating Margin % | -327.83 |
| Pre-tax Margin (%) | -1,851.22 |
| Quick Ratio | 2.57 |
| Current Ratio | 2.65 |
| ROA % (ttm) | -75.34 |
| ROE % (ttm) | -100.87 |
| ROIC % (ttm) | -15.27 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.16 |
RLFTF Number of Guru Trades
RLFTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:RLFTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RLFTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Relief Therapeutics Holding SA Insider Transactions
No Available Data
News about OTCPK:RLFTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers